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ABSTRACT
Urinary catheters are one of the most widely used invasive devices in Intensive Care Units (ICUs), and its 
insertion is a major contributor to the development of complications, increasing hospitalization time and 
costs. Objectives: The study seeks to evaluate the direct cost of the Bladder Catheterization (BC) procedure, 
and also to carry out its partial economic evaluation in ICU hospitalized patients who were either bearing or 
not bearing a Urinary Tract Infection (UTI). Methods: It is a descriptive study that has used partial economic 
evaluation by analyzing patients’ records. Results: 48.45% of the BC costs are due to the urine collection 
system, followed by lidocaine hydrochloride (20.38%) and Foley catheter (12.70%). The costs’ increase of 
the BC procedure, coupled with the UTI treatment, represent more than 18 times the cost increase in ICUs, 
which extrapolates the value of UTI treatments in R$3,537,692.79 considering the Brazilian healthcare system. 
Conclusion: The costs of UTI treatment associated with the BC procedure have a large impact on the hospital 
budget, requiring an economic analysis in order to implement a rational allocation of resources.
Keywords: Costs, cost analysis, urinary catheterization, nursing economics, nursing.
RESUMO
Objetivos: Valorar os itens do custo direto do cateter vesical de demora (CVD) e realizar sua avaliação econômica parcial nos pacientes 
internados na Unidades de Terapia Intensiva (UTIs) com e sem infecções do trato urinário (ITU). Método: Trata-se de estudo descritivo 
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do tipo série de casos, que utilizou a avaliação econômica parcial para 
estudar os custos diretos do cateterismo vesical de demora, analisando 
prontuários dos pacientes. Resultados: 48,45% do custo do CVD deve-se 
ao sistema coletor de urina, seguido do cloridrato de lidocaína (20,38%) 
e cateter Foley (12,70%). O aumento dos custos do CVD, associado ao 
tratamento da ITU, representa um aumento do custo em 18 vezes em 
ambas as UTIs, extrapolando o valor dos tratamentos em R$ 3.537.692,79, 
abrindo possibilidades para trabalhos de avaliação do custo-efetividade. 
Conclusão: A ITU associada ao CVD traz grande impacto no orçamento 
hospitalar, cabendo à análise econômica a alocação racional de recursos. 
Descritores: Custos e análise de custo, Cateterismo urinário, Economia da 
enfermagem, Enfermagem.
RESUMEN
Los catéteres urinarios (CAU) son uno de los dispositivos invasivos 
más ampliamente utilizados en las unidades de cuidados intensivos 
(UCI), y su inserción es un importante contribuyente al desarrollo de 
complicaciones, hospitalización y costos. Objetivos: Evaluar el coste 
directo de la CAU y desarrollar una evaluación económica parcial en 
pacientes hospitalizados en la UCI con y sin infección del tracto urinario. 
Métodos: Estudio descriptivo mediante el análisis de los archivos de los 
pacientes. Resultados: 48,45% del costo de la UC se deben al sistema de 
recolección de orina, seguido de clorhidrato de lidocaína (20,38%) y el 
catéter de Foley (12,70%). El aumento de los costos de la CAU, asociados 
con el tratamiento en la UCI representan >18 veces. Extrapolando el valor 
de los tratamientos UCI para el sistema de salud brasileño, la diferencia 
sería R$ 3,537,692.79. Conclusión: ITU asociada al catéter tiene un gran 
impacto en el presupuesto de hospital.
Descriptores: Costos y análisis de costo, Cateterismo urinario, Economía 
de la enfermería, Enfermería.
INTRODUCTION
Nowadays, the health system is undergoing an important 
financial crisis that threatens the survival of hospital 
organizations, considering the aging of the population and 
the appearance of new therapies and diagnostic tests, raising 
the costs of treating various pathologies.1-3
In the United States, the government’s concern 
about hospital costs forced the Centers for Medicare & 
Medicaid Services to create some rules to reduce costs. 
The ten complications displayed in the high-cost, high-
volume hospital environment were selected and that were 
reasonably simple complications to be avoided with the 
application of evidence-based guidelines. Under these 
rules, if a patient developed any complications that were 
not present at admission - such as a Urinary Tract Infection 
(UTI) caused by the Urinary Catheter (UC) - hospital 
billing would not include this type of complication, as if it 
was not present.4
The UC is one of the most used invasive devices 
in health care, and it is the insertion procedure that 
contributes the most to the development of complications, 
depending on the technique, the drainage system used, the 
care applied, the duration of catheterization, the presence 
of comorbidities and old age.5
In a particular study, it was presented that the surgical 
center is the area of the hospital where the majority of 
the UCs were inserted (71.3%), followed by the Intensive 
Care Unit (ICU) (16.9%) and emergency room (5.9 %). 
About 12% to 16% of patients within ICU had a UC 
inserted at some time during hospitalization period. 
According to epidemiological data, 35% to 45% of all 
infections acquired in the hospital are ICUs, 80% of which 
are related to the UC use.8-10
In a prospective study, which has had 2,412 
participating patients and performed in a Thai hospital, 
a full cost evaluation was carried out and the efficacy 
of a quality-of-care program was evaluated, with an 
intervention performed in order to remind physicians to 
remove unnecessary UCs. After the intervention, there 
was a reduction in the unnecessary insertion rate of the 
UC, in the ICU average rate associated with UC from 21.5 
to 5.2 infections per 1,000 catheters per day (p<0.001), 
in the duration of UC use by 11 (p<0.001) and in the 
hospitalization time (average of 16 vs. 5 days, p<0.001). 
The monthly hospital costs of antibiotics to treat the 
UTI associated with UC were reduced by 63% (p<0.001) 
and the hospitalization costs for each patient during the 
intervention were reduced by 58% (p<0.001).11
Knowing that the UC insertion is a type of intervention 
in which the nursing acts directly and actively, in addition 
to being an invasive and potentially traumatic procedure 
capable of attacking the lower urinary tract, it is necessary 
for the professional to have scientific knowledge and 
technical ability, seeking a balance between patient safety 
and cost-effectiveness.12
According to the Methodological Guidelines for Studies 
about Economic Evaluation and Health Technology, 
from the Health Ministry, it is possible to identify the 
values added to technological alternatives towards health 
care, as well as to decide about the rational allocation of 
the investment, becoming a valuable administrative tool 
in the decision-making process for managers of health 
institutions.12,13 In order to investigate the economic 
aspects related to nursing care, we target to analyze the cost 
of the Bladder Catheterization (BC) procedure in patients 
admitted to ICU. 
METHOD
It is a descriptive study with a case series approach type, 
which used the partial economic evaluation to study the 
direct costs of the BC procedure. This type of evaluation 
has been widely used in the health area, being limited in the 
calculation of direct and indirect costs for different health 
interventions.
The study was conducted in two ICUs in two large 
university hospitals (identified in the study by “ICU A” and 
“ICU B”), located in Rio de Janeiro city. These institutions 
were chosen because both belong to the public health 
education system, and also because the source of data 
collection about the value of cost items was the same.
Regarding the UC insertion procedure, it is performed 
exclusively by the nurse in the sector in the ICU A, except 
when the patient is submitted to a surgical procedure and 
the UC is inserted inside the surgical center by the attending 
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physician. In the ICU B, the same procedure occurs, with the 
difference that, within the surgical center, the procedure is 
performed by the circulating nurse.
The average data collection time in each institution was of 
60 days, from Monday to Friday, during the daytime period. 
The sample consisted of two groups, the first one by the 
patients hospitalized within the two ICUs, who used the UC 
during data collection, and the second by the coordinating 
nurses of the ICUs.
For the first group, those older than 18 years old that 
did not undergo prophylactic therapy with antibiotics for 
ICU stay prior to the insertion procedure of the UC and 
were submitted to it during the current ICU stay were 
considered eligible. Those excluded from the study were 
those who were part of a clinical trial and/or had a history 
of bacteriuria, as they could have altered the costs due to 
the use of extra resources in these cases. Considering the 
57 hospitalized patients during data collection, 33 belonged 
to ICU A and 24 to ICU B. From the application of the 
inclusion and exclusion criteria, the sample consisted of 27 
sick patients.
The second group was composed by nurses from the 
routine ICU service to obtain information about the BC 
procedure, because the nurse performed most of the 
invasive procedures in both institutions. Those nurses 
who were part of the routine of the unit were included in 
the study, outside of the effective ICU for at least one year; 
and excluding those who are on vacation, on medical leave 
or maternity leave. Thus, 02 nurses were included in the 
sample, with 01 of each unit.
For the calculation of the procedure costs , the inputs 
costs and human resources cost were taken into account, 
concerning the time spent by the those in the accomplishment 
of the procedure. The salary of ICU A nurse was taken from 
the website of the Foundation for Support towards Research, 
Teaching and Care and that of ICU B was withdrawn from 
the Public Contest Notice for the post of Higher University 
Technician - nurse profile.14,15
A form was used to collect data on cost items: nurse’s 
wage (adapted according to the time spent in the procedure), 
inputs used in the insertion of the UC and inputs used in 
the case of UTI treatment. This information was collected 
from the pricing banks that were made available by the 
Health Ministry.16,17
The cost of the inputs was calculated from the average 
costs found, using the simple rule of three. Adding the 
cost of the inputs and the wage of the professional, the 
total cost of the procedure was obtained. Only direct costs 
were considered.
The documentary analysis of the medical records of 
the hospitalized patients in the ICU who were using UC 
for the collection of clinical and epidemiological data were 
employed, using a specific form. The data collected was 
organized into electronic databases by typing in spreadsheets 
of the application Microsoft Excel 2007, from where they 
were exported. The analysis model used was the partial 
economic evaluation, using simple statistics.
For the analysis of the main complication related to UC, 
as well as the partial cost analysis, due to lack of treatment 
protocol in both institutions, the leaflets of the respective 
medicines administered and analyzed with the costs of the 
treatments performed in both places were used. The project is 
under the Certificado de Apresentação para Apreciação Ética 
(CAAE) [Certificate of Presentation for Ethical Appraisal] 
No. 04626512.9.0000.5285, Legal Opinion No. 95.220, in the 
Ethics Committee in Research from the Federal University 
of the State of Rio de Janeiro.
RESULTS AND DISCUSSION
Data were analyzed for 27 patients, 11 men and 16 
women in both units. It was observed that the largest 
number of hospitalized patients was female (59.3%), with an 
average age of 67.38 years (Dp=17.0). Males accounted for 
40.7% (n=11), with a average age of 54.3 years (Dp=22.2), 
corroborating the fact that the UTI is the second nosocomial 
infection in the population, predominantly among adults 
of advanced age (above 65 years) and females.18,19
It was observed that the average time of the UC use was 8 
to 15 days (37%), in the two institutions. A group of researchers 
demonstrated an UTI risk of 2.5% for one day of catheterization, 
10.0% for 2 to 3 days, 12.2% for 4 to 5 days, reaching 26.9% for 
the same duration or greater than six days.19 When we correlated 
the data, it was observed that 63% of patients who used UC for 
more than 6 days presented a 26.9% risk of developing UTIs. 
The surgical center was the area of the hospital where most of 
the UCs were inserted (55.6%), followed by the ICU (44.4%). In 
relation to the professional who inserted the UC, the nurse is the 
professional who most performs the procedure (63%), followed 
by the physician (29.6%) and the nursing technician (7.4%).
It was not possible to identify UTI associated to UC in 
the sample, and it may be questioned about possible masked 
infection, since the drugs used have a broad spectrum and 
cover the microorganisms that are normally involved in 
UTIs.20,21 Perhaps this is one of the most significant factors in 
which they cover the presence of the UTI in these patients, 
which present numerous predisposing factors and not by 
prophylactic antibiotic therapy, according to guidelines of 
the Brazilian Society of Urology.22
Table 1 shows the costs of the inputs used in the BC 
procedure collected at the Health Pricing Bank from 
the Health Ministry. It was observed that 48.45% of the 
procedure cost for insertion of the UC is due to the closed 
collector system (most expensive item), followed by 
lidocaine hydrochloride and Foley catheter, which represent 
20.38% and 12.70%, respectively. 
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Table 1 – Cost of the inputs utilized in the BC procedure. Brazil, 2013.
Inputs
Average 
quantitative 
by procedure
Major cost* 
(R$)
Minor cost* 
(R$)
Average cost by 
procedure † (R$) SD %
Syringe, 20 mL 01 0.49 0.46 0.22 0.02 3.25
Syringe, 10 mL 01 0.31 0.17 0.18 0.10 2.66
Procedure glove 02 0.26 0.22 0.25 0.03 0.30
Sterile glove 01 1.75 0.45 0.58 0.92 8.57
Disposable needle, 25 mm x 7 mm 01 4.35 0.02 0.03 3.06 0.44
Foley probe, No. 20 01 2.35 0.69 0.86 1.18 12.70
Urine collector, closed system 01 6.90 0.02 3.28 4.86 48.45
Surgical Mask† 0.02 5.00 3.82 0.002 0.83 0.03
Distilled water 01 0.36 0.02 0.08 0.24 1.18
Tape, 100 mm x 4,50 m† 10 cm 8.01 0.04 0.06 5.64 0.89
Lidocaine hydrochloride, 2%§ 01 3.39 0.76 1.38 1.86 20.38
Chlorhexidine digluconate 2%, antiseptic† 10 mL 20.08 5.59 0.08 10.25 1.18
Total R$6.78
Source: *Values rounded to two decimal places, referring to the highest and lowest values paid by the health institutions supported by the Sistema 
Único de Saúde (SUS) [Unified Health System]; †Values proportional to the quantity used in the procedure; ‡Values consulted for 01/24/2013; §The use 
of one tube per procedure was considered. ||Product specifications have been simplified.
Regarding the procedure’s hand labor, we have observed 
that the nurse from the ICU A receives R$3.84 for the 
procedure, 40.74% less than the nurse from the ICU B 
(R$6.48). Among the various procedures that the nurse 
performs, the BC takes from 20 to 40 minutes, according to 
its difficulty and time of professional experience. These data 
were collected from the interview with the nurses of the units 
in order to calculate the cost with human resources, regarding 
the time spent during the procedure accomplishment.
When analyzing Table 2, we can observe the difference in 
the values referring to each dose of antibiotic. In the ICU B, the 
value of the antimicrobial treatment for UTI is R$11.61, while 
in the ICU A this amount is R$13.72, representing an increase 
of R$2.11 or 18.17%. Although these values do not correspond 
to the same antibiotic, it is known that there are other types 
of treatment for the UTI that could be considered, from the 
point of view of their effectiveness until the creation of specific 
regional protocols that would be applied in all institutions 
with the purpose of standardizing and reducing costs.22 
Table 2 - Cost of the inputs utilized in the UTI antibiotic treatment in the ICU A and ICU B (per dose). Rio de Janeiro, RJ, Brazil, 2013.
Inputs
Average 
quantitative 
by procedure
Major 
cost* 
(R$)
Minor 
cost* 
(R$)
Average cost 
by procedure 
† (R$)
SD %
Cefepime hydrochloride, 2 g, injectable 
lyophilic powder 
01 12.25 8.35 9.44 2.76 68.80
Equipment for infusion of NaCl 0.9% 
solution
01 1.93 1.48 1.71 0.32 12.46
ICU A
Intravenous catheter 01 82.5 0.05 0.81 58.30 5.90
Procedure glove 02 0.27 0.23 0.25 0.03 1.82
Gauze compress (pack with 10 un.) 01 22.96 0.03 1.49 16.21 10.86
Hydrous ethyl alcohol, 70% 5 mL 4.23 0.33 0.02 2.76 0.15
Total R$13.72
Piperacillin 4 g, plus tazobactam 500 mg, 
injectable
01 10.63 4.02 7.33 2.34 63.14
ICU B
Equipment for infusion of NaCl 0.9% 
solution
01 1.93 1.48 1.71 0.32 12.46
Intravenous catheter 01 82.5 0.05 0.81 58.30 5.90
Procedure glove 02 0.27 0.23 0.25 0.03 1.82
Gauze compress (pack with 10 un.) 01 22.96 0.03 1.49 16.21 10.86
Hydrous ethyl alcohol, 70% 5 mL 4.23 0.33 0.02 2.76 0.15
Total R$11.61
Source: *Values rounded to two decimal places, referring to the highest and lowest values paid by the health institutions supported by the Sistema 
Único de Saúde (SUS) [Unified Health System]; †Values proportional to the quantity used in the procedure; ‡Values consulted for 01/24/2013; 
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It was observed that the cost with the antibiotic amounts 
to 63.14% in the cost of BC with infection in the ICU B and 
68.80% of costs in the ICU A. So, the concern with hospital 
costs becomes evident.
Considering that the professional’s hand labor represents 
a fixed cost for the institution and that the treatment for 
the UTI is administered several times a day (according to 
prescription and protocol), it becomes evident what this cost 
represents for the public payer.
Considering the fact that there were no UTI bearing 
patients in the sample and expecting to be able to perform 
an analysis of the costs of BC between the groups of patients 
without UTI and with the disease, it was decided to rely on 
the literature in order to perform such analysis.
The costs of the UC insertion procedure were calculated 
from the list of input costs, as presented previously, and 
the cost of the hand labor concerning the time spent by 
the professional. In order to obtain the total cost of the UC 
insertion procedure, the sum of these values was performed, 
and when there was a UTI, the costs with the disease 
treatment were added, as shown in Table 3. 
Table 3 – Partial economic assessment of the BC with and without UTI, per institution. Rio de Janeiro, RJ, Brazil, 2013.
Cost per institution (R$)
ICU A ICU B
BC cost
Inputs utilized in the UC insertion 6.78
10.62
6.78
13.26
Nurse’s hand labor 3.84 6.48
Treatment 
cost of the 
UTI
Antibiotic treatment (piperacillin 4g + 
tazobactam 500mg) 3 times per day, 
over 7 days*
- - -
243.81
(11.61 x 3 doses 
x 7 days)
Antibiotic treatment (Cefepime 
hydrochloride 2g) 2 times per day, 
over 7 days†
-
192.08
(13.72 x 2 doses 
x 7 days)
- -
Total cost per institution R$202.70 R$257.07
*7 days of treatment every 8 hours; †7 days of treatment every 12 hours.
By analyzing Table 3, we have observed a robust difference 
in the values referring to each dose of antibiotic. In the ICU 
B, the procedure cost, including seven days of antimicrobial 
treatment, is R$257.07, while in the ICU A this amount is 
R$202.70, representing an increase of R$54.37 (26.82%) 
between these two institutions. We can argue over the cost 
differences in each ICU, the choice of the most expensive 
treatment, if both antibiotics can be used for the UTI treatment.
The costs for the treatment of the UTI represent 1.42 times 
the average cost in relation to patients without the infection. 
As we can observe, the increase in costs of the BC procedure, 
when associated with the treatment of the UTI, reaches 18.09 
times in the ICU A and 18.37 times in the ICU B. From the 
valuation of inputs and hand labor involved, it was estimated 
that the value to perform the insertion procedure of the UC 
in both units would correspond to 2% of the total cost of 
the UTI procedure. It is worth mentioning that these values 
correspond to one patient over seven days of treatment.
The partial economic evaluation data, collected in the 
study, allow it to be applied to real data. In order to visualize 
the possible consequences in the use of each treatment for 
the UTI in the Brazilian scenario, a small extrapolation of 
the data collected for the national scenario was performed.
In the UHS database, it was possible to select the 
number of hospitalizations of high complexity patients 
in public hospitals during 2012 (since there were no data 
for the year 2013) and the average time of permanence, 
according to each federative region.23 About 16.9% of 
patients admitted to ICUs use UC. Considering the data 
collected in the aforementioned database, we would have 
represented 102,102 patients in the Brazilian territory who 
used UC in ICU.
The incidence of UTI associated with UC is 6.13%. 
Therefore, complementing the reasoning, we could estimate 
that 65,067 of these patients would present UTI as a 
complication related to UC use ([604.154 patients * 16.9%] 
- 6.13%).24
When we used these data based on the scientific 
literature, with those collected in the UHS database and 
when we applied in each unit studied (ICU A and ICU B), 
we could estimate the value for the Brazilian health system, 
if one of the treatments economically evaluated was applied. 
Table 4 shows the difference of R$3,537,692.79 that draws 
a lot of attention, which allows other work possibilities that 
can evaluate the cost-effectiveness of each treatment for the 
UTI, and in different protocol types. 
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Table 4 – Incremental cost of UTI treatment associated to UC use according to the number of hospital admissions in Brazil in 2012.
Treatment of the UTI Procedure cost with no infection (R$)
Procedure cost + 
Treatment of the UTI 
over 7 days (R$)
Total number of UTI 
cases related to UC 
use during 2012 (R$)
Total cost (R$)
According to
the ICU A
10.61 202.70
65.067
13,189,080.90
According to
the ICU B
13.25 257.07 16,726,773.69
Incremental* -R$3,537,692.79
*Additional cost.
In the case of the ICU A, the cost of the UTI treatment 
over seven days seems to be of lower value (R$202,70). By 
extrapolating this value to the Brazilian scenario, we see how 
much public money is being spent. The same would apply to 
the ICU B (R$257.07). And from these data, it can be asked: 
is this treatment cost-effective? This question remains open, 
creating new possibilities for economic studies.
Although economic analysis studies in the nursing area 
are not yet frequent, these are extremely important for rational 
decision making as a management tool, where all scenarios 
and possibilities are evaluated, as well as serve as a tool to 
enable the professional to ground his/her choices on inputs, 
machinery, among other resources used in health care.25
In closed units such as those here studied and especially 
in relation to the BC procedure, the nurse occupies a position 
of extreme relevance. It was observed in the data presented 
that a neglected nursing care towards the patient with UC 
could lead to possible clinical complications, exemplified 
here by the UTI as the most common among them, with 
the consequent increase in hospital costs. The participation 
of nurses and their awareness of their work value can 
avoid consequences that might be prevented, as well as an 
indispensable contribution to the rational allocation of 
health resources. 
CONCLUSION
The study showed that, with regards to the cost of UC use 
in patients admitted to the ICU in two university hospitals 
located in Rio de Janeiro city, the value paid by the nurse’s 
labor costs less than the inputs used. The relevance of this 
data to the management area, especially related to the 
economics of public health services, should be treated as an 
object of additional studies within the nursing research field, 
as well as other related areas.
The analysis of the projections and the verification of the 
data collected in the field bring a concern with the future of 
the health system and how much it is necessary to plan the 
action of preventive campaigns. In the case of a society with a 
prominently elderly future, the current timing for these types 
of campaigns provides time to be interpreted as “long-term 
investment” in reducing future social spending.
As this was a new study, some difficulties were 
encountered, especially with regards to either the lack or 
limited national information available on the topic; studies 
related to the UC insertion and permanence procedure; the 
identification and treatment of UTI and the expected results 
after treatment. In this sense, the instruments of collection 
and the contribution of the professionals of the units 
involved in the accomplishment of the procedures, as well 
as those experts in this type of analysis, were of great value 
for this study.
The study is relevant because of the reflections raised 
about the cost and consequences of the necessary care for the 
UTI prevention, as well as the contribution it may generate for 
the implementation of protocols in the public health network.
The economic evaluation of health technologies is a 
relatively current topic in nursing, demanding development 
and reinvigoration within the lines of research. The information 
generated from this research method serves as a guide for 
health professionals and researchers in the area so that they 
are more qualified to innovate and seek the knowledge needed 
to reduce costs within the health system, through the choice of 
the best technological option for rational allocation of costs in 
any area of activity, or in the health promotion environment at 
either hospital or home level.
When the professional, regardless of his/her working field, 
knows the economic value of his work, he/she becomes able to 
assist in the planning, acquisition and maintenance of resources. 
In the case of nurses, their orientation is of great value because 
at the moment that alternatives that can add value to the care 
practice are present, there is a return to the institution caused 
by the greater effectiveness and cost reduction, in addition to 
becoming more attractive for the market needs.
Although the difference in costs of the BC with UTI 
between ICU A and ICU B was “only” R$54.37, it was 
possible to carry out another projection with the data 
collected. Based on the “real-world” data available on the 
Health Ministry website, a possible savings of R$3,537,692.79 
with high complexity patients hospitalized in 2012 was 
identified. Despite the small difference in the treatments, 
there is robustness when these are quantified at the national 
level, expanding new possibilities of works that can evaluate 
the cost-effectiveness of each treatment for UTI in different 
types of protocols.
It was concluded that the cost of the BC procedure 
without UTI in the institutions surveyed was R$10.62 in 
ICU A and R$13.26 in ICU B, and that the treatment of UTI 
added R$192.08 and R$243.81, representing an important 
public financial impact, which allows the reallocation of 
these resources to double the attendance, to acquire new 
technologies, to qualify the labor force, among others 
suitable actions. 
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